Metastatic Colorectal Cancers Recruiting Phase 1 Trials for Regorafenib (DB08896)

Also known as: Colorectal Cancer Metastatic / Metastatic Colorectal Cancer / Metastatic Colorectal Cancer (MCRC) / Cancer - Metastatic Colorectal / Colorectal Cancer, Metastatic

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03712943Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal CancerTreatment